BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16139132)

  • 1. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.
    Sasso FC; Torella D; Carbonara O; Ellison GM; Torella M; Scardone M; Marra C; Nasti R; Marfella R; Cozzolino D; Indolfi C; Cotrufo M; Torella R; Salvatore T
    J Am Coll Cardiol; 2005 Sep; 46(5):827-34. PubMed ID: 16139132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?
    Simons M
    J Am Coll Cardiol; 2005 Sep; 46(5):835-7. PubMed ID: 16139133
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease.
    Zygalaki E; Kaklamanis L; Nikolaou NI; Kyrzopoulos S; Houri M; Kyriakides Z; Lianidou ES; Kremastinos DT
    Clin Biochem; 2008 Jan; 41(1-2):82-7. PubMed ID: 17961532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phospho-adenosine monophosphate-activated protein kinase and vascular endothelial growth factor in a model of chronic heart failure.
    Heidrich F; Sossalla S; Schotola H; Vorkamp T; Ortmann P; Popov AF; Coskun KO; Rajab TK; Friedrich M; Sohns C; Hinz J; Bauer M; Quintel M; Schöndube FA; Schmitto JD
    Artif Organs; 2010 Nov; 34(11):969-79. PubMed ID: 21092039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
    Jesmin S; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yamaguchi N; Mowa CN; Maeda S; Hattori Y; Miyauchi T
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1030-40. PubMed ID: 17148754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Shimojo N; Masuzawa K; Yamaguchi I; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression and the role of vascular endothelial growth factor (VEGF) in human normal and myocardial infarcted heart].
    Shinohara K
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):978-93. PubMed ID: 7959603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
    Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
    J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
    Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
    Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
    Jesmin S; Sakuma I; Hattori Y; Fujii S; Kitabatake A
    Diabetologia; 2002 Mar; 45(3):402-15. PubMed ID: 11914746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
    Blann AD; Belgore FM; McCollum CN; Silverman S; Lip PL; Lip GY
    Clin Sci (Lond); 2002 Feb; 102(2):187-94. PubMed ID: 11834138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of messenger RNAs encoding vascular endothelial growth factor and its receptors during the development and maintenance of caprine corpora lutea.
    Kawate N; Tsuji M; Tamada H; Inaba T; Sawada T
    Mol Reprod Dev; 2003 Feb; 64(2):166-71. PubMed ID: 12506348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers.
    Pufe T; Paulsen F; Petersen W; Mentlein R; Tsokos M
    J Pathol; 2003 May; 200(1):130-6. PubMed ID: 12692851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats.
    Wang XH; Chen SF; Jin HM; Hu RM
    Life Sci; 2009 Feb; 84(7-8):240-9. PubMed ID: 19135459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.
    Krenn K; Klepetko W; Taghavi S; Paulus P; Aharinejad S
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):35-41. PubMed ID: 17481912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts.
    Felaco M; Grilli A; De Lutiis MA; Patruno A; Libertini N; Taccardi AA; Di Napoli P; Di Giulio C; Barbacane R; Conti P
    Ann Clin Lab Sci; 2001 Apr; 31(2):179-86. PubMed ID: 11337908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
    Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
    Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.